A double blind controlled study of high-dose L-Deprenyl in the treatment of Parkinson's disease
Frankel, J.P. and Kempster, P.A. and Stibe, C.M.H. and Eatough, Virginia and Nathanson, M. and Lees, A.J. and Stern, G. (1989) A double blind controlled study of high-dose L-Deprenyl in the treatment of Parkinson's disease. Clinical Neuropharmacology 12 (5), pp. 448-451. ISSN 0362-5664.
Abstract
The conventional dose of deprenyl used in Parkinson's disease is 10 mg/day, having been established by in vitro platelet studies and clinical evaluation. Twelve patients with Parkinson's disease on treatment with L-dopa who showed evidence of wearing-off effects or motor oscillation were studied in a double-blind, placebo-controlled, crossover trial to compare conventional doses of deprenyl with higher doses (up to 40 mg/day) and placebo. We did not find higher doses of deprenyl to be superior to conventional doses and in 17% of cases treatment had to be withdrawn because of side effects.
Metadata
| Item Type: | Article |
|---|---|
| School: | Birkbeck Faculties and Schools > Faculty of Science > School of Psychological Sciences |
| Depositing User: | Sarah Hall |
| Date Deposited: | 25 Nov 2019 16:11 |
| Last Modified: | 02 Aug 2023 17:55 |
| URI: | https://eprints.bbk.ac.uk/id/eprint/30061 |
Statistics
Additional statistics are available via IRStats2.
Archive Staff Only (login required)
 |
Edit/View Item |